U.S. flag

An official website of the United States government

NM_000059.4(BRCA2):c.3723T>G (p.Phe1241Leu) AND Hereditary cancer-predisposing syndrome

Germline classification:
Conflicting interpretations of pathogenicity (2 submissions)
Last evaluated:
Apr 3, 2024
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000132213.13

Allele description [Variation Report for NM_000059.4(BRCA2):c.3723T>G (p.Phe1241Leu)]

NM_000059.4(BRCA2):c.3723T>G (p.Phe1241Leu)

Gene:
BRCA2:BRCA2 DNA repair associated [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
13q13.1
Genomic location:
Preferred name:
NM_000059.4(BRCA2):c.3723T>G (p.Phe1241Leu)
HGVS:
  • NC_000013.11:g.32338078T>G
  • NG_012772.3:g.27599T>G
  • NM_000059.4:c.3723T>GMANE SELECT
  • NP_000050.2:p.Phe1241Leu
  • NP_000050.3:p.Phe1241Leu
  • LRG_293t1:c.3723T>G
  • LRG_293:g.27599T>G
  • LRG_293p1:p.Phe1241Leu
  • NC_000013.10:g.32912215T>G
  • NM_000059.3:c.3723T>G
  • p.F1241L
Protein change:
F1241L
Links:
dbSNP: rs587782723
NCBI 1000 Genomes Browser:
rs587782723
Molecular consequence:
  • NM_000059.4:c.3723T>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000187295Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Apr 3, 2024)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Citation Link,

SCV003846822University of Washington Department of Laboratory Medicine, University of Washington
criteria provided, single submitter

(Dines et al. (Genet Med. 2020))
Likely benign
(Mar 23, 2023)
germlinecuration

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, curation

Citations

PubMed

EMMA, a cost- and time-effective diagnostic method for simultaneous detection of point mutations and large-scale genomic rearrangements: application to BRCA1 and BRCA2 in 1,525 patients.

Caux-Moncoutier V, Castéra L, Tirapo C, Michaux D, Rémon MA, Laugé A, Rouleau E, De Pauw A, Buecher B, Gauthier-Villars M, Viovy JL, Stoppa-Lyonnet D, Houdayer C.

Hum Mutat. 2011 Mar;32(3):325-34. doi: 10.1002/humu.21414. Epub 2011 Feb 8.

PubMed [citation]
PMID:
21120943

Integrated analysis of germline and somatic variants in ovarian cancer.

Kanchi KL, Johnson KJ, Lu C, McLellan MD, Leiserson MD, Wendl MC, Zhang Q, Koboldt DC, Xie M, Kandoth C, McMichael JF, Wyczalkowski MA, Larson DE, Schmidt HK, Miller CA, Fulton RS, Spellman PT, Mardis ER, Druley TE, Graubert TA, Goodfellow PJ, Raphael BJ, et al.

Nat Commun. 2014;5:3156. doi: 10.1038/ncomms4156.

PubMed [citation]
PMID:
24448499
PMCID:
PMC4025965
See all PubMed Citations (5)

Details of each submission

From Ambry Genetics, SCV000187295.9

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

The p.F1241L variant (also known as c.3723T>G), located in coding exon 10 of the BRCA2 gene, results from a T to G substitution at nucleotide position 3723. The phenylalanine at codon 1241 is replaced by leucine, an amino acid with highly similar properties. This alteration has been reported in patients with a personal and/or family history of breast and/or ovarian cancer (Caux-Moncoutier V et al. Hum Mutat. 2011 Mar;32(3):325-34; Kanchi KL et al. Nat Commun. 2014;5:3156; Santonocito C et al. Cancers (Basel). 2020 May;12; Yao L et al. J Hum Genet, 2022 Nov;67:639-642). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From University of Washington Department of Laboratory Medicine, University of Washington, SCV003846822.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (1)

Description

Missense variant in a coldspot region where missense variants are very unlikely to be pathogenic (PMID:31911673).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024